Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?

Hendrik Ungefroren; Björn Konukiewitz; Rüdiger Braun; Ulrich Friedrich Wellner; Tobias Keck; Jens Uwe Marquardt

doi:10.3390/cancers15030581

Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?

Hendrik Ungefroren^*, Björn Konukiewitz, Rüdiger Braun, Ulrich Friedrich Wellner, Tobias Keck, Jens Uwe Marquardt

^*Corresponding author for this work

University of Kiel

3 Citations (Scopus)

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10% that is the lowest of all cancer types [...].

Original language	English
Article number	581
Journal	Cancers
Volume	15
Issue number	3
ISSN	2072-6694
DOIs	https://doi.org/10.3390/cancers15030581
Publication status	Published - 18.01.2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/cancers15030581

Fingerprint

Dive into the research topics of 'Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?'. Together they form a unique fingerprint.

Cite this

Ungefroren, H., Konukiewitz, B., Braun, R., Wellner, U. F., Keck, T., & Marquardt, J. U. (2023). Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma? Cancers, 15(3), Article 581. https://doi.org/10.3390/cancers15030581

@article{31489449f6bb4097a8ab7c30e5c7cbec,

title = "Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?",

abstract = "Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10\% that is the lowest of all cancer types [...].",

author = "Hendrik Ungefroren and Bj{\"o}rn Konukiewitz and R{\"u}diger Braun and Wellner, \{Ulrich Friedrich\} and Tobias Keck and Marquardt, \{Jens Uwe\}",

year = "2023",

month = jan,

day = "18",

doi = "10.3390/cancers15030581",

language = "English",

volume = "15",

journal = "Cancers",

issn = "2072-6694",

number = "3",

}

Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma? / Ungefroren, Hendrik; Konukiewitz, Björn; Braun, Rüdiger et al.
In: Cancers, Vol. 15, No. 3, 581, 18.01.2023.

Research output: Journal Articles › Editorial

TY - JOUR

T1 - Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity

T2 - Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?

AU - Ungefroren, Hendrik

AU - Konukiewitz, Björn

AU - Braun, Rüdiger

AU - Wellner, Ulrich Friedrich

AU - Keck, Tobias

AU - Marquardt, Jens Uwe

PY - 2023/1/18

Y1 - 2023/1/18

N2 - Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10% that is the lowest of all cancer types [...].

AB - Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related mortality worldwide, with a 5-year-survival rate below 10% that is the lowest of all cancer types [...].

UR - https://www.scopus.com/pages/publications/85147813229

UR - https://www.mendeley.com/catalogue/152c372b-63a5-35a7-a619-c095caa98d1e/

U2 - 10.3390/cancers15030581

DO - 10.3390/cancers15030581

M3 - Editorial

C2 - 36765537

AN - SCOPUS:85147813229

SN - 2072-6694

VL - 15

JO - Cancers

JF - Cancers

IS - 3

M1 - 581

ER -

Elucidation of the Role of SMAD4 in Epithelial–Mesenchymal Plasticity: Does It Help to Better Understand the Consequences of DPC4 Inactivation in the Malignant Progression of Pancreatic Ductal Adenocarcinoma?

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this